Researchers emphasize changes are small, typically return to normal in next menstrual cycle.

OHSU Center for Women’s Health reiterates safety, efficacy of mifepristone, a drug FDA-approved to end early pregnancy for more than 20 years.

This week’s FDA granting of marketing authorization of implantable shock absorber marks first new surgical treatment in decades for osteoarthritis of the knee.

With hundreds of tissue donors, it is the most extensive guide ever created; could lead to better diagnosis, treatment of diseases associated with ‘bad luck or bad habits.’

Last updated Tuesday, July 23, 2024.